Financhill
Back

Morphic Holding Quote, Financials, Valuation and Earnings

Morphic Holding Price Quote

$35.21
+0.82 (+2.38%)
(Updated: March 28, 2024 at 6:55 PM ET)

Morphic Holding Key Stats

Buy
65
Morphic Holding (MORF) is a Buy

Day range:
$32.43 - $34.57
52-week range:
$19.35 - $63.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.90
P/B ratio:
2.47%

Volume:
284.9K
Avg. volume:
433K
1-year change:
-8.46%
Market cap:
$1.7B
Revenue:
$521K
EPS:
$-3.49

How Much Does Morphic Holding Make?

Data Unavailable

Is Morphic Holding Growing As A Company?

Data Unavailable

Morphic Holding Stock Price Performance

  • Did Morphic Holding Stock Go Up Last Month?
    Morphic Holding share price went down by -9.88% last month
  • Did MORF's Share Price Rise Over The Last Year?
    MORF share price fell by -8.46% over the past 1 year

What Is Morphic Holding 52-Week High & Low?

Morphic Holding Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Morphic Holding?

  • How Much Debt Does Morphic Holding Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Morphic Holding Have?
    Cash and short term investments quarterly total is $704.3M
  • What Is Morphic Holding’s Book Value Per Share?
    Book value per share is 14.01

Is Morphic Holding Cash Flow Positive?

  • What Is MORF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$112.3M
  • What Is Morphic Holding’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $453.4M
  • What Is Morphic Holding’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$341.8M

Morphic Holding Return On Invested Capital

Data Unavailable

Morphic Holding Earnings Date & Stock Price

Morphic Holding Competitors

  • Who Are Morphic Holding's Competitors?
    Below is a list of companies who compete with Morphic Holding or are related in some way:
    • iBio Inc (IBIO)
    • Keros Therapeutics Inc (KROS)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Morphic Holding Dividend Yield

Data Unavailable

Morphic Holding Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -13.91%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 56.75
Upside from Last Price: 65.02%

Major Shareholders

  • How many MORF shares are owned by institutional investors?
    76M MORF shares are owned by institutional investors
  • How many MORF shares are owned by insiders?
    5.1M MORF shares are owned by insiders